
Sothema announced on October 28 the signing of an agreement to acquire 100 percent of the capital of Ramo Pharm, a Casablanca company founded in 1999 that specializes in food supplements.

Its brands, sold through pharmacies, include Enrouex, ZENmag and Matervit, positioned on ENT, immunity, stress and sleep, and women’s health.
For the pharmaceutical group based in Bouskoura, which turns fifty this year, the deal lays the foundations of a fourth division, “Wellness & Consumer Health,” alongside general medicine and chronic care, specialty products and dialysis.
Chief executive Lamia Tazi plans to rely on Sothema’s international distribution networks to carry Ramo Pharm’s brands beyond Morocco.
The deal remains subject to clearance from the Competition Council. The statement gives neither the price nor the timetable of the transaction.
Photo: Sothema.


